Steven F Bellon

This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in Therapeutic Compounds. Top assignees: Amgen Inc., Constellation Pharmaceuticals, Inc., Genentech, Inc.. Active years: 2002-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven F Bellon. Retrieved from https://idiyas.com/inventor/steven-f-bellon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 2)

% Patents Active = 91.7

CIPO Patents = 4

EPO Patents = 14 (Patent Applications = 7)

Average Co-Inventor Count = 10.1

ph-index = 9

Forward Citations = 216(Granted Patents)

Location History:

Wellesly, MA (US) (2002)
Wellesley, MA (US) (2003 - 2018)
Cambridge, MA (US) (2018 - 2019)

Company Filing History:

Constellation Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2002-2019

Loading Chart...

Areas of Expertise:

Therapeutic Compounds

Protein Kinase Inhibitors

Cancer Treatment

Pyrazolo Compounds

Heterocycles

Fused Heterocyclic Derivatives

Substituted Amide Derivatives

Nitrogen-Containing Heterocycles

Bis-Aryl Kinase Inhibitors

Crystallized P38 Complexes

Inhibitors of P38

Substituted Pyridines

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10258603 - Therapeutic compounds and uses thereof (2019-04-16),

2. 10183009 - Therapeutic compounds and uses thereof (2019-01-22),

3. 10150767 - Therapeutic compounds and uses thereof (2018-12-11),

4. 10035801 - Pyrazolo compounds and uses thereof (2018-07-31),

5. 9505767 - Pyrazolo[1,5-A]pyrimidin-7(4H)-onehistone demethylase inhibitors (2016-11-29),

6. 9066954 - Fused heterocyclic derivatives and methods of use (2015-06-30),

7. 8691838 - Heterocycles as protein kinase inhibitors (2014-04-08),

8. 8685983 - Method of treating cancer with substituted amide derivatives (2014-04-01),

9. 8476434 - Protein kinase modulators and method of use (2013-07-02),

10. 8314087 - Nitrogen-containing heterocyclyl ketones and methods of use (2012-11-20),

11. 8217177 - Fused heterocyclic derivatives and methods of use (2012-07-10),

12. 8212041 - Fused heterocyclic derivatives and methods of use (2012-07-03),

13. 8178557 - Compounds and methods of use (2012-05-15),

14. 8088794 - Substituted amide derivatives and methods of use (2012-01-03),

15. 8017601 - Bis-aryl kinase inhibitors and method (2011-09-13),

Title: The Innovative Journey of Steven F. Bellon

Introduction: Steven F. Bellon, a talented inventor hailing from Wellesley, MA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Steven F. Bellon's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a novel medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: With a career spanning over two decades, Steven F. Bellon has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has garnered recognition for its creativity and practicality.

Collaborations: Throughout his career, Steven F. Bellon has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Steven F. Bellon's passion for innovation and his dedication to pushing the boundaries of what is possible have solidified his reputation as a pioneering inventor in the field of technology. His contributions continue to inspire the next generation of inventors to think outside the box and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.